Patients Come First - New Jersey
Recent News About Patients Come First - New Jersey
-
NJ Health Reform Group: 'The result of the exploitation of 340B is that New Jersey patients ultimately pay higher drug prices'
The head of a New Jersey health reform group said the federal 340b drug program is causing New Jersey patients to pay higher drug prices.
-
Executive director of Patients Come First: 'The biggest flaw in the 340B program is that the discounts don’t have to go to the beneficiaries'
Concerns are mounting over the federal 340B drug pricing program, which was intended to provide affordable medications to low-income patients, as evidence suggests that some large health systems are using the program’s benefits to generate profits. The 340B program, established to supply safety-net hospitals with deeply discounted drugs, is now the second-largest federal prescription drug initiative, surpassing Medicare Parts B and D in scale.
-
Patients Come First Director: Government price controls lead to 'loss of innovation in the marketplace,' patients suffering
Jeanette Hoffman, the executive director of advocacy organization Patients Come First (PCF), said government interference with prices in the drug industry leads to a "loss of innovation in the marketplace," negatively impacting patients and their treatment options.
-
NJ Health Care Reform Group: ‘PBMs have jeopardized patient care, cost taxpayers, and reduced patient choice’
The head of a New Jersey health care reform group said pharmacy benefit managers (PBMs) "have jeopardized patient care, cost taxpayers, and reduced patient choice" after a recent report from the Federal Trade Commission (FTC) was reviewed by New Jersey legislators.
-
New Jersey one of 30 states that allows copay accumulators
New Jersey is one of thirty states that allows copay accumulators.
-
NJ Health Care Reform Group: PBMs ‘work to keep the true costs of medicine hidden from consumers’
The head of a New Jersey health care reform group said that pharmacy benefit managers (PBMs) have “capitalized on an opaque system” and are working to “keep the true costs of medicine hidden from consumers.”
-
NJ Health Care Reform Group: Government price setting an obstacle to ‘research and cures’
The executive director of Patients Come First - New Jersey (PCF-NJ) said that government price setting in health care will negatively impact “access to research and cures.”
-
Health Analyst: NJ hospital patients aren't receiving drug price savings due from federal program
A national health policy analyst said New Jersey patients served by a hospital participating in the federal 340b drug program should be concerned the drug savings aren’t being passed along to them.
-
NJ Health Care Reform Group: Insurance companies shouldn't pick prescription drugs for patients
Insurance companies “denying coverage” of the prescription drugs she needed to deal with chronic migraines is one reason Jeannette Hoffman wanted to become the executive director for the newly-formed group, Patients Come First-New Jersey.
-
‘Patients Come First’ launches in New Jersey, announces executive director
A new “patient advocacy” organization, Patients Come First, today launched in New Jersey, announcing longtime New Jersey communications professional Jeannette Hoffman as the group’s executive director.